A carregar...

Aromatase and CDK4/6 Inhibitor-Induced Musculoskeletal Symptoms: A Systematic Review

SIMPLE SUMMARY: Aromatase inhibitor-induced musculoskeletal symptoms (AIMSS) occurs in up 50% of postmenopausal patients and is the reason for treatment discontinuation in 25% of patients with breast cancer. CDK4/6 inhibitors have been established in the treatment of hormone receptor-positive (HR) b...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Cancers (Basel)
Main Authors: Andrikopoulou, Angeliki, Fiste, Oraianthi, Liontos, Michalis, Dimopoulos, Meletios-Athanasios, Zagouri, Flora
Formato: Artigo
Idioma:Inglês
Publicado em: MDPI 2021
Assuntos:
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC7865932/
https://ncbi.nlm.nih.gov/pubmed/33530456
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/cancers13030465
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!